Amgen may face new competition in anemia drug arena

05/16/2007 | Forbes

Amgen, already under a recommendation of added warnings for its anemia drugs, faces possible new competition from a Roche anemia drug. Federal regulators are scheduled to decide this week on preliminary approval for Roche's Mircera, which also uses a biotech protein to increase red blood cell production.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA